This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Stefanie Geisler - Innovator in Neurodegenerative Disease Research
Introduction
Stefanie Geisler is an accomplished inventor based in St. Louis, MO (US). She is affiliated with Washington University, where she contributes to groundbreaking research in the field of neurodegenerative diseases. Although she currently holds no granted patents, her work is focused on developing innovative therapeutic strategies.
Latest Patent Applications
Stefanie Geisler's notable patent application is titled "Dominant Negative SARM1 Molecules as a Therapeutic Strategy for Neurodegenerative Diseases or Disorders." This invention provides compositions that are useful as inhibitors of SARM1 activity, along with pharmaceutical compositions and methods for their use. The application highlights the potential of dominant negative SARM1 molecules in treating neurodegenerative or neurological diseases or disorders.
Conclusion
Stefanie Geisler's research and patent application reflect her commitment to advancing the understanding and treatment of neurodegenerative diseases. Her innovative approach may pave the way for new therapeutic options in the future.